Eichhorst, Barbara (2021). Vaccination against COVID-19: a challenge in CLL. Blood, 137 (23). S. 3153 - 3155. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Full text not available from this repository.

Abstract

In this issue of Blood, Herishanu et al report on the efficacy of the BNT162b2 messenger RNA (mRNA) COVID-19 vaccine in untreated and treated patients with chronic lymphocytic leukemia (CLL).(1) Their findings show low response rates to vaccination in CLL, similar to previous reports with other vaccines.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Eichhorst, BarbaraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-573295
DOI: 10.1182/blood.2021011935
Journal or Publication Title: Blood
Volume: 137
Number: 23
Page Range: S. 3153 - 3155
Date: 2021
Publisher: AMER SOC HEMATOLOGY
Place of Publication: WASHINGTON
ISSN: 1528-0020
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/57329

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item